BIOMAT Database Logo BIOMAT Database Logo

Design and one-pot synthesis of 2-thiazolylhydrazone derivatives as influenza neuraminidase inhibitors. 2017

Keyang Yuan, and Mengwu Xiao, and Ying Tan, and Jiao Ye, and Yongle Xie, and Xiaoxiao Sun, and Aixi Hu, and Wenwen Lian, and Ailin Liu
College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, China.

Two series of novel 2-thiazolylhydrazone derivatives were designed and synthesized via one-pot reaction of benzaldehyde derivatives, [Formula: see text]-haloketones and thiosemicarbazide. The structures of compounds 1 and 2 were characterized by [Formula: see text] NMR and [Formula: see text] NMR, and compound 1g was further confirmed by X-ray crystallography. All of the target compounds were evaluated for their NA inhibitory activity against influenza viral neuraminidase (H1N1) in vitro, and the results showed that many compounds exhibited moderate to strong inhibitory activities against influenza viral neuraminidase (H1N1). Among them, compounds 1p, 1q and 2c showed the most potent inhibitory activities with [Formula: see text] values ranging from 10.50 to [Formula: see text]. Our structure-activity relationship analysis indicated that 2-thiazolylhydrazone is an effective scaffold for NA inhibitors and that introducing an ethoxycarbonyl group to the 5-position of thiazole ring could enhance inhibitory potency. Molecular docking was performed on the most active compounds 1p and 2c to provide more insight into their mechanism of interaction.

UI MeSH Term Description Entries
D009439 Neuraminidase An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992) Sialidase,Exo-alpha-Sialidase,N-Acylneuraminate Glycohydrolases,Oligosaccharide Sialidase,Exo alpha Sialidase,Glycohydrolases, N-Acylneuraminate,N Acylneuraminate Glycohydrolases,Sialidase, Oligosaccharide
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006835 Hydrazones Compounds of the general formula R:N.NR2, as resulting from the action of hydrazines with aldehydes or ketones. (Grant & Hackh's Chemical Dictionary, 5th ed) Hydrazone
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D053118 Influenza A Virus, H1N1 Subtype A subtype of INFLUENZA A VIRUS with the surface proteins hemagglutinin 1 and neuraminidase 1. The H1N1 subtype was responsible for the Spanish flu pandemic of 1918 and 2009 H1N1 pandemic. H1N1 Influenza Virus,H1N1 Virus,H1N1 subtype,H1N1v Viruses,Influenza A (H1N1)pdm09,Influenza A (H1N1)pdm09 Virus,Influenza A H1N1, Variant Virus,Swine-Origin Influenza A H1N1 Virus,H1N1 Influenza Viruses,H1N1 Viruses,H1N1 subtypes,H1N1v Virus,Influenza Virus, H1N1,Swine Origin Influenza A H1N1 Virus,Virus, H1N1,Virus, H1N1 Influenza,Virus, H1N1v,subtype, H1N1
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Keyang Yuan, and Mengwu Xiao, and Ying Tan, and Jiao Ye, and Yongle Xie, and Xiaoxiao Sun, and Aixi Hu, and Wenwen Lian, and Ailin Liu
Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors.
March 2021, European journal of medicinal chemistry,
Keyang Yuan, and Mengwu Xiao, and Ying Tan, and Jiao Ye, and Yongle Xie, and Xiaoxiao Sun, and Aixi Hu, and Wenwen Lian, and Ailin Liu
Design, synthesis and biological evaluation of honokiol derivatives as influenza neuraminidase inhibitors.
November 2019, Journal of Asian natural products research,
Keyang Yuan, and Mengwu Xiao, and Ying Tan, and Jiao Ye, and Yongle Xie, and Xiaoxiao Sun, and Aixi Hu, and Wenwen Lian, and Ailin Liu
Design, synthesis, and biological activity of thiazole derivatives as novel influenza neuraminidase inhibitors.
August 2011, Journal of enzyme inhibition and medicinal chemistry,
Keyang Yuan, and Mengwu Xiao, and Ying Tan, and Jiao Ye, and Yongle Xie, and Xiaoxiao Sun, and Aixi Hu, and Wenwen Lian, and Ailin Liu
Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.
December 1997, Journal of medicinal chemistry,
Keyang Yuan, and Mengwu Xiao, and Ying Tan, and Jiao Ye, and Yongle Xie, and Xiaoxiao Sun, and Aixi Hu, and Wenwen Lian, and Ailin Liu
Design and synthesis of 4-alkyl-2-amino(acetamino)-6-aryl-1,3-thiazine derivatives as influenza neuraminidase inhibitors.
September 2013, Archiv der Pharmazie,
Keyang Yuan, and Mengwu Xiao, and Ying Tan, and Jiao Ye, and Yongle Xie, and Xiaoxiao Sun, and Aixi Hu, and Wenwen Lian, and Ailin Liu
Synthesis and evaluation of 1,4,5,6-tetrahydropyridazine derivatives as influenza neuraminidase inhibitors.
July 1999, Bioorganic & medicinal chemistry letters,
Keyang Yuan, and Mengwu Xiao, and Ying Tan, and Jiao Ye, and Yongle Xie, and Xiaoxiao Sun, and Aixi Hu, and Wenwen Lian, and Ailin Liu
Design and synthesis of thiazolylhydrazone derivatives as inhibitors of chitinolytic N-acetyl-β-d-hexosaminidase.
November 2018, Bioorganic & medicinal chemistry,
Keyang Yuan, and Mengwu Xiao, and Ying Tan, and Jiao Ye, and Yongle Xie, and Xiaoxiao Sun, and Aixi Hu, and Wenwen Lian, and Ailin Liu
Design, Synthesis, and Biological Effect Studies of Novel Benzofuran-Thiazolylhydrazone Derivatives as Monoamine Oxidase Inhibitors.
March 2024, ACS omega,
Keyang Yuan, and Mengwu Xiao, and Ying Tan, and Jiao Ye, and Yongle Xie, and Xiaoxiao Sun, and Aixi Hu, and Wenwen Lian, and Ailin Liu
Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors.
April 2011, Bioorganic & medicinal chemistry,
Keyang Yuan, and Mengwu Xiao, and Ying Tan, and Jiao Ye, and Yongle Xie, and Xiaoxiao Sun, and Aixi Hu, and Wenwen Lian, and Ailin Liu
Design, one-pot synthesis, computational and biological evaluation of diaryl benzimidazole derivatives as MEK inhibitors.
October 2023, Journal of biomolecular structure & dynamics,
Copied contents to your clipboard!